The company focuses on areas of high medical need like Oncology, Neurosciences, and Rare Diseases, and believes that technologies such as Cell and Gene Therapy, Gene Editing, mRNA/RNAi will revolutionize medicine. Kineticos Ventures seeks to support innovative biotech companies that are leveraging these disruptive technologies to transform the healthcare industry.